Congress Park Capital’s Idexx Laboratories IDXX Stock Holding History

Congress Park Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-450	Closed	-$288K	–	131
2025 Q3	$288K	Hold	450	–	–	0.09%	104
2025 Q2	$241K	Buy	+450	New	+$215K	0.08%	100
2024 Q4	–	Sell	-450	Closed	-$227K	–	113
2024 Q3	$227K	Hold	450	–	–	0.08%	107
2024 Q2	$219K	Hold	450	–	–	0.09%	108
2024 Q1	$243K	Hold	450	–	–	0.11%	102
2023 Q4	$250K	Sell	450 -25	-5%	-$11.7K	0.12%	103
2023 Q3	$208K	Sell	475 -25	-5%	-$12.5K	0.11%	112
2023 Q2	$251K	Hold	500	–	–	0.13%	115
2023 Q1	$250K	Hold	500	–	–	0.13%	109
2022 Q4	$204K	Buy	+500	New	+$194K	0.12%	129
2022 Q3	–	Sell	-600	Closed	-$210K	–	138
2022 Q2	$210K	Hold	600	–	–	0.13%	122
2022 Q1	$328K	Hold	600	–	–	0.16%	108
2021 Q4	$395K	Hold	600	–	–	0.19%	95
2021 Q3	$373K	Sell	600 -100	-14%	-$67.2K	0.19%	94
2021 Q2	$442K	Hold	700	–	–	0.22%	88
2021 Q1	$343K	Hold	700	–	–	0.19%	97
2020 Q4	$350K	Sell	700 -150	-18%	-$67.1K	0.21%	85
2020 Q3	$334K	Hold	850	–	–	0.21%	77
2020 Q2	$281K	Hold	850	–	–	0.22%	78
2020 Q1	$206K	Hold	850	–	–	0.19%	80
2019 Q4	$222K	Hold	850	–	–	0.16%	90
2019 Q3	$231K	Hold	850	–	–	0.19%	79
2019 Q2	$241K	Buy	+850	New	+$209K	0.19%	83

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Congress Park Capital's IDXX Position: Q4 2025 in Review

Congress Park Capital sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 450 shares — an estimated $288K sold.

Congress Park Capital first reported a position in IDXX in Q2 2019 and held it in 23 quarters. The position peaked at $442K in Q2 2021. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

Congress Park Capital reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
Congress Park Capital sold 450 Idexx Laboratories shares in Q4 2025, an estimated $288K.
Congress Park Capital first reported a position in Idexx Laboratories in Q2 2019 and held it in 23 quarters.
Congress Park Capital's Idexx Laboratories position peaked at $442K in Q2 2021.
1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Congress Park Capital's 13F filing for Q4 2025, filed 14 Jan 2026.